Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11124538 Neuroactive steroids, compositions, and uses thereof

Patent 11124538 was granted and assigned to SAGE Therapeutics on September, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 11 Sep, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Sep, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12083131 Neuroactive steroids, compositions, and uses thereof
0
Edits on 14 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 14 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12060386 Compositions and methods for treating CNS disorders
0
Edits on 31 Jul, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 31 Jul, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 4 Apr, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 4 Apr, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11945836 Compositions and methods for treating CNS disorders
0
Edits on 12 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 12 Dec, 2023
Edits made to:
Article (+76 characters)
Article

Patent abstract

Described herein are neuroactive steroids of the Formula (I):

Edits on 25 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 25 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=1112453800
Edits on 6 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 6 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
SAGE Therapeutics
SAGE Therapeutics
0
Current Assignee
SAGE Therapeutics
SAGE Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
111245380
Date of Patent
September 21, 2021
0
Patent Application Number
201904300
Date Filed
April 30, 2019
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=111245380
Edits on 25 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
SAGE Therapeutics
SAGE Therapeutics
0
Current Assignee
SAGE Therapeutics
SAGE Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
111245380
Date of Patent
September 21, 2021
0
Patent Application Number
201904300
Date Filed
April 30, 2019
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=111245380
Edits on 6 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 6 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=11124538
Edits on 22 Sep, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 22 Sep, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 11124538 Neuroactive steroids, compositions, and uses thereof

Infobox
Is a
Patent
Patent
Patent applicant
SAGE Therapeutics
SAGE Therapeutics
Current assignee
SAGE Therapeutics
SAGE Therapeutics
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
11124538
Date of patent
September 21, 2021
Patent application number
20190430
Date Filed
April 30, 2019

Find more entities like US Patent 11124538 Neuroactive steroids, compositions, and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.